EUVIMEDEUVIMED entdecken
Crossref

Inflammatory bowel disease‐associated serrated lesions with dysplasia are frequently associated with advanced neoplasia: supporting a unified classification approach

Dorukhan Bahceci iD, Anita Sejben iD, Lindsay Yassan iD, Gregory Miller iD, Xiaoyan Liao iD, Huaibin Mabel Ko iD, Marcela Salomao iD, Masato Yozu iD, Gregory Y Lauwers iD, Won-Tak Choi iD

Histopathology · 2025

DOI: 10.1111/his.15448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Dorukhan Bahceci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California at San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Precancerous Conditions, Adenoma, Colorectal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Inflammatory bowel disease (IBD)‐associated serrated lesions are categorized into three distinct subtypes: traditional serrated adenoma (TSA)‐like lesion, sessile serrated lesion (SSL)‐like lesion, and serrated lesion, not otherwise specified (NOS). Although the risk of neoplastic progression of serrated lesions without dysplasia has not been shown to exceed that of sporadic cases, the clinicopathologic features of the three serrated subtypes with dysplasia remain poorly understood in the context of IBD. Methods and Results We analysed 87 serrated lesions with dysplasia (collectively referred to as serrated dysplasia) identified endoscopically in 58 IBD patients, including 51 (59%) TSA‐like dysplasia, 24 (28%) SSL‐like dysplasia, and 12 (14%) serrated dysplasia NOS. Inclusion criteria required all three serrated subtypes to show morphologic evidence of dysplasia and to be located within areas of colitis. We also compared the clinicopathologic features of serrated dysplasia with those of 239 conventional (adenomatous) dysplastic lesions from 149 IBD patients. The cohort included 39 (67%) men and 19 (33%) women, with a mean age of 54 years and a mean IBD duration of 20 years. Most patients had ulcerative colitis ( n = 41; 71%) and pancolitis ( n = 48; 83%). The majority of serrated lesions with dysplasia had a polypoid or visible endoscopic appearance ( n = 73; 84%), with a mean size of 1.4 cm, and were found in the left colon ( n = 66; 76%). Most lesions ( n = 73; 84%) demonstrated low‐grade dysplasia at the time of biopsy diagnosis, whereas high‐grade dysplasia (HGD) was identified in the remaining 14 (16%) lesions. SSL‐like dysplasia was more frequently associated with ulcerative colitis (94%) compared to TSA‐like dysplasia (67%) and serrated dysplasia NOS (56%) ( P = 0.042). Although only seven (12%) patients had a concurrent history of primary sclerosing cholangitis, it was exclusively identified in the TSA‐like dysplasia group (19% versus 0% in both the SSL‐like dysplasia group and the serrated dysplasia NOS group; P = 0.017). Serrated dysplasia NOS more commonly demonstrated HGD at the time of biopsy diagnosis (42%) compared to TSA‐like dysplasia (12%) and SSL‐like dysplasia (13%) ( P = 0.022). Serrated dysplasia NOS was also more frequently associated with synchronous and/or metachronous nonconventional dysplasia (60%) compared to TSA‐like dysplasia (16%) and SSL‐like dysplasia (9%) ( P = 0.037). Serrated dysplasia, regardless of subtype, was associated with high rates of advanced neoplasia (HGD or colorectal cancer) at the previous biopsy site or in the same colonic segment during follow‐up. Within a mean follow‐up time of 13 months, advanced neoplasia was detected in 50% of the TSA‐like dysplasia group, 67% of the SSL‐like dysplasia group, and 100% of the serrated dysplasia NOS group ( P = 0.622). Moreover, at least one‐third of patients in each group (58% in the TSA‐like dysplasia group, 44% in the SSL‐like dysplasia group, and 33% in the serrated dysplasia NOS group; P = 0.332) developed synchronous/metachronous dysplasia, with at least 50% of these lesions progressing to advanced neoplasia within a mean follow‐up time of 11 months ( P = 1.000). The serrated dysplasia group showed nearly six times the incidence of advanced neoplasia upon follow‐up (59%) compared to the conventional dysplasia group (10%) ( P < 0.001).

Conclusion

TSA‐like dysplasia, SSL‐like dysplasia, and serrated dysplasia NOS show distinct clinicopathologic features. However, all three serrated subtypes were associated with high rates of advanced neoplasia (50%–100%) during follow‐up, suggesting that these lesions could potentially be combined into one diagnostic category, such as serrated dysplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPrecancerous ConditionsAdenomaColorectal NeoplasmsColonic PolypsColonic NeoplasmsHumansFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

colorectal cancerdysplasiainflammatory bowel diseaseserrated dysplasiasessile serrated lesiontraditional serrated adenoma

Autor:innen und Institutionen

  • Department of Pathology, University of California at San Francisco, San Francisco, CA, USA.
  • Department of Pathology, Albert Szent-Györgyi Medical School, Szeged, Hungary.
  • Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Envoi Specialist Pathologists, Kelvin Grove, Queensland, Australia.
  • Department of Pathology, University of Rochester, Rochester, NY, USA.
  • Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.

ORCID-Profile: Dorukhan Bahceci, Anita Sejben, Lindsay Yassan, Gregory Miller, Xiaoyan Liao, Huaibin Mabel Ko, Marcela Salomao, Masato Yozu, Gregory Y Lauwers, Won-Tak Choi

Zitieren

APA

Bahceci, D., Sejben, A., Yassan, L., Miller, G., Liao, X., Ko, H. M., Salomao, M., Yozu, M., Lauwers, G. Y., & Choi, W. T. (2025). Inflammatory bowel disease‐associated serrated lesions with dysplasia are frequently associated with advanced neoplasia: supporting a unified classification approach. Histopathology. https://doi.org/10.1111/his.15448

Vancouver

Bahceci D, Sejben A, Yassan L, Miller G, Liao X, Ko HM, et al. Inflammatory bowel disease‐associated serrated lesions with dysplasia are frequently associated with advanced neoplasia: supporting a unified classification approach. Histopathology. 2025. doi:10.1111/his.15448

BibTeX
@article{Bahceci2025,
  author = {Bahceci, Dorukhan and Sejben, Anita and Yassan, Lindsay and Miller, Gregory and Liao, Xiaoyan and Ko, Huaibin Mabel and Salomao, Marcela and Yozu, Masato and Lauwers, Gregory Y and Choi, Won-Tak},
  title = {Inflammatory bowel disease‐associated serrated lesions with dysplasia are frequently associated with advanced neoplasia: supporting a unified classification approach},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15448}
}
Kostenlos starten →